All Infection Prevention & Control articles – Page 43
-
NewsScientists use computer model to improve hospitals’ ability to limit spread of drug-resistant infections
The computer model improves on traditional methods like contact tracing by inferring asymptomatic carriers in the spread of antibiotic-resistant infections.
-
NewsSmart toilet designs in Cambodia held promise, but a key piece was missing
A smart toilet design introduced in rural Cambodia was supposed to change lives—keeping families safe and protecting the environment. However, while households reported that they liked the new system, a crucial piece was missing: using it correctly.
-
NewsStudy unveils structure, identification and characterization of the RibD-enolase complex in Francisella
A study aiming to identify anti-tularemia drug targets determined the atomic structure and identified its components of the native RibD-enolase protein complex in Francisella novicida.
-
NewsNew nanogel technology destroys drug-resistant bacteria in hours
A novel technology shows over 99.9% effectiveness against Pseudomonas aeruginosa (P. aeruginosa). It centres on a heteromultivalent nanogel: a flexible particle made by crosslinking polymers and adding sugar residues (galactose and fucose) alongside antimicrobial peptides.
-
NewsGSK and Fleming Initiative scientists unite to target AMR with advanced AI
GSK and the Fleming Initiative have announced six major new research programmes, called ‘Grand Challenges’ which harness some of the best scientific expertise and the latest technologies, including advanced AI, to find new ways to slow the progress of antimicrobial resistance (AMR).
-
NewsScripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
Scripps Research scientists will purchase high-performance computing equipment to accelerate the identification of more effective HIV vaccine candidates through enhanced computational infrastructure, reduced data-processing bottlenecks, and state-of-the-art artificial intelligence (AI) technology.
-
News$3.7 million awarded for research into sand flies, vectors of parasitic disease leishmaniasis
Professor Gideon Wasserberg at UNC Greensboro has been awarded a prestigious $3.7 million National Institutes of Health R01 grant to advance his research on controlling sand flies, the vectors of the parasitic disease leishmaniasis.
-
NewsPhase 2 clinical trial results show potential to shorten TB treatment time
New clinical trial results show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the potential to improve tuberculosis (TB) treatment when combined with pretomanid and linezolid in a treatment regimen known as “SPaL.”
-
NewsResearchers expand virus-based treatment options for antibiotic-resistant infections
Phages are extremely specific about which strains of a bacterial species they will attack. This has limited their effectiveness against the most antibiotic-resistant strains. To overcome this problem, the research team “trained” the phages by allowing them to evolve together with the bacteria in a controlled laboratory setting for 30 days.
-
NewsDid US cities’ indoor vaccine mandates affect COVID-19 vaccination rates and outcomes?
New research reveals that despite widespread adoption of indoor vaccine mandates in major US cities during the COVID-19 pandemic, there is no consistent evidence that these policies significantly increased vaccination rates or reduced COVID-19–related outcomes. The findings contrast with those from other countries, as national mandates abroad boosted vaccine uptake.
-
NewsApriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
-
NewsThe leading causes of mass mortality events in sea urchins are pathogens, storms, and extreme temperatures
Researchers have identified the primary drivers of sea urchin mass mortality events over recent decades: pathogens, storms, and extreme temperatures. The team have developed an innovative method for genetic sampling in marine environments - using a swab similar to a COVID-19 test, to enable rapid and non-invasive monitoring of marine animals and underwater disease outbreaks.
-
NewsBiomedical Sciences researcher receives nearly $7 million in federal grants to fight STIs
Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received nearly $7 million in two, five-year federal grants to develop vaccines and therapeutics to combat sexually transmitted infections (STIs).
-
NewsExperts urge continued hepatitis B vaccine birth doses for newborns
In a new commentary, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth. Hepatitis B vaccines are safe and effective with over one billion doses administered worldwide.
-
NewsKorea University College of Medicine’s Vaccine Innovation Center selected as lead institution for 2025 Korea-ARPA-H Health Security Project
The Vaccine Innovation Center at Korea University College of Medicine has been selected as the lead institution for a health security research initiative under the Ministry of Health and Welfare’s “2025 Korea-ARPA-H Project.”
-
NewsNew test could allow for more accurate Lyme disease diagnosis
Researchers have developed a new way to detect the Lyme disease bacterium Borrelia burgdorferi, allowing for faster and more accurate diagnosis.
-
NewsNew test could speed detection of three serious regional fungal infections
Researchers have developed a new molecular test capable of detecting three major pathogenic fungi at once — and with a much quicker turnaround than traditional methods.
-
NewsTyphoid conjugate vaccine demonstrates strong safety and immunogenicity: Results from Phase 3 study
PATH and EuBiologics Co., LTD have announced Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.® Source: CDC/ Armed Forces Institute of Pathology, Charles N. Farmer This photomicrograph reveals some of the histopathology exhibited in a lymph node tissue ...
-
NewsRainfall and temperature shape mosquito fauna in Atlantic Forest bromeliads, including malaria vectors
Results from a study of mosquito larvae conducted in a natural area in the municipality of São Paulo (Brazil) may help estimate the effects of climate change on disease transmission risk in the biome.
-
CareersSummer studentship: Jonas investigates how metals influence bacterial ecosystems
Jonas Flohr from Portsmouth reports back on his AMI-sponsored summer studentship at Durham University investigating how metals influence bacterial ecosystems.